NO20015003L - Nukleinsyrer kodende for CD40/CD40L kimeriske polypeptider, fremgangsmåter for fremstilling og anvendelse derav - Google Patents

Nukleinsyrer kodende for CD40/CD40L kimeriske polypeptider, fremgangsmåter for fremstilling og anvendelse derav

Info

Publication number
NO20015003L
NO20015003L NO20015003A NO20015003A NO20015003L NO 20015003 L NO20015003 L NO 20015003L NO 20015003 A NO20015003 A NO 20015003A NO 20015003 A NO20015003 A NO 20015003A NO 20015003 L NO20015003 L NO 20015003L
Authority
NO
Norway
Prior art keywords
preparation
methods
nucleic acids
acids encoding
chimeric polypeptides
Prior art date
Application number
NO20015003A
Other languages
English (en)
Other versions
NO20015003D0 (no
Inventor
Frank Dicker
Thomas Friess
Gerd Maass
Ulrich Pessara
Werner Scheuer
Stefan Seeber
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP99107611A external-priority patent/EP1067194A1/en
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO20015003D0 publication Critical patent/NO20015003D0/no
Publication of NO20015003L publication Critical patent/NO20015003L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
NO20015003A 1999-04-16 2001-10-15 Nukleinsyrer kodende for CD40/CD40L kimeriske polypeptider, fremgangsmåter for fremstilling og anvendelse derav NO20015003L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99107611A EP1067194A1 (en) 1999-04-16 1999-04-16 Vectors containing a gene coding for CD40 and/or CD40L under the control of a cytokine-inducible promoter which is a human acute phase amyloid A gene promoter. Methods for their production and uses thereof
EP99113967 1999-07-17
PCT/EP2000/003318 WO2000063395A1 (en) 1999-04-16 2000-04-13 Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof

Publications (2)

Publication Number Publication Date
NO20015003D0 NO20015003D0 (no) 2001-10-15
NO20015003L true NO20015003L (no) 2001-10-15

Family

ID=26152970

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015003A NO20015003L (no) 1999-04-16 2001-10-15 Nukleinsyrer kodende for CD40/CD40L kimeriske polypeptider, fremgangsmåter for fremstilling og anvendelse derav

Country Status (8)

Country Link
EP (1) EP1173589A1 (no)
JP (1) JP2003508016A (no)
AR (1) AR023482A1 (no)
AU (1) AU3966200A (no)
CA (1) CA2369820A1 (no)
IL (1) IL144952A0 (no)
NO (1) NO20015003L (no)
WO (1) WO2000063395A1 (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE541860T1 (de) 2000-10-02 2012-02-15 Novartis Vaccines & Diagnostic Humane antikörper gegen cd40 zur therapie von b- zell tumoren
AU2002221780A1 (en) * 2000-10-31 2002-05-15 F.Hoffmann-La Roche Ag Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
PL1684869T3 (pl) 2003-11-04 2011-12-30 Novartis Vaccines & Diagnostics Inc Sposoby leczenia nowotworów wywodzących się z limfocytów B
ATE474599T1 (de) 2003-11-04 2010-08-15 Novartis Vaccines & Diagnostic Verwendung von antagonisten-anti-cd40- monoklonalen antikörpern zur behandlung von multiplem myelom
PT1680141E (pt) 2003-11-04 2010-12-20 Novartis Vaccines & Diagnostic Métodos terapêuticos para tumores sólidos que expressam o antigénio de superfície celular cd40
JP4765037B2 (ja) 2003-11-04 2011-09-07 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 慢性リンパ球性白血病の処置のためのアンタゴニスト抗ｃｄ４０モノクローナル抗体の使用
WO2005044306A2 (en) 2003-11-04 2005-05-19 Chiron Corporation Use of antagonist anti-cd40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
AU2006247134B2 (en) 2005-05-18 2012-05-10 Novartis Ag Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
UA94264C2 (ru) 2006-04-21 2011-04-26 Новартис Аг Стабильная жидкая фармацевтическая композиция, которая содержит антагонистическое моноклональное антитело к cd40
MY188753A (en) 2006-09-18 2021-12-29 Univ Arkansas Compositions and methods of enhancing immune responses
WO2009059018A1 (en) 2007-10-30 2009-05-07 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to flagellated bacterium
CA3156538C (en) 2007-11-01 2023-12-12 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to eimeria
JP5568807B2 (ja) * 2008-06-06 2014-08-13 静岡県 プロテオミクス解析を用いたメラノーママーカーの同定
EA023058B1 (ru) 2010-01-21 2016-04-29 Дзе Борд Оф Трастиз Оф Дзе Юниверсити Оф Арканзас Вакцинные векторы и способы усиления иммунных ответов
PT2579901T (pt) 2010-06-09 2019-11-05 Univ Arkansas Vacina e métodos para reduzir infeção por campylobacter
WO2012075111A1 (en) 2010-11-30 2012-06-07 Novartis Ag Uses of anti-cd40 antibodies in combination therapy for b cell-related cancers
MX2015010555A (es) 2013-02-14 2015-09-28 Univ Arkansas Composiciones y metodos para mejorar las respuestas inmunes ante una infeccion por eimeria o una infeccion limitante por eimeria.
CA2906079C (en) 2013-03-15 2022-08-23 The Board Of Trustees Of The University Of Arkansas Compositions and methods of enhancing immune responses to enteric pathogens
AR108688A1 (es) 2016-05-03 2018-09-19 Univ Arkansas Vector de vacuna de levadura que incluye polipéptidos inmunoestimuladores y antigénicos, métodos para su uso
WO2018094309A2 (en) * 2016-11-21 2018-05-24 Nant Holdings Ip, Llc Fractal combination therapy
WO2019241592A1 (en) * 2018-06-14 2019-12-19 Nantbio, Inc. Tnf-type receptor-ligand fusion proteins and methods
US20210369825A1 (en) * 2018-10-05 2021-12-02 Nantcell, Inc. Cd40 and cd40l combo in an adv vaccine vehicle

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993008207A1 (en) * 1991-10-25 1993-04-29 Immunex Corporation Novel cytokine
US5716805A (en) * 1991-10-25 1998-02-10 Immunex Corporation Methods of preparing soluble, oligomeric proteins
US7070771B1 (en) * 1996-12-09 2006-07-04 Regents Of The University Of California Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells

Also Published As

Publication number Publication date
NO20015003D0 (no) 2001-10-15
WO2000063395A1 (en) 2000-10-26
JP2003508016A (ja) 2003-03-04
AU3966200A (en) 2000-11-02
CA2369820A1 (en) 2000-10-26
IL144952A0 (en) 2002-06-30
AR023482A1 (es) 2002-09-04
EP1173589A1 (en) 2002-01-23

Similar Documents

Publication Publication Date Title
NO20015003D0 (no) Nukleinsyrer kodende for CD40/CD40L kimeriske polypeptider, fremgangsmåter for fremstilling og anvendelse derav
ZA200110161B (en) Anti-avB3 recombinant human antibodies, nucleic acids encoding same and methods of use.
WO2003023008A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
NO20024774L (no) [1,4`]-bipiperidinforbindelsr, fremgangsmate til fremstilling derav og anvendelse dera, farmasoytisk preparat, samt mellomprodukter
AU2002221780A1 (en) Nucleic acids encoding cd40/cd40l chimeric polypeptides, methods for their production and uses thereof
EP1576169A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THE SAME, AND METHODS OF USE THEREOF
AU9633301A (en) Paad domain-containing polypeptides, encoding nucleic acids, and methods of use
EP1487864A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES AND METHODS OF USE THEREOF
AU2002356534A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
EP1446419A4 (en) THERAPEUTIC POLYPEPTIDES FOR THOSE CODING NUCLEIC ACIDS AND METHOD OF ADMINISTRATION
EP1432726A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS CODED FOR THEM, AND METHOD OF USE
EP1401858A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS COATING THEREOF AND METHOD OF USE
AU2003217956A8 (en) Therapeutic polypeptides, nucleic acids encoding same and methods of use
EP1695078A4 (en) METADHERINE POLYPEPTIDES, CODING NUCLEIC ACIDS AND METHOD OF USE
AU2003247537A8 (en) Chd5 encoding nucleic acids, polypeptides, antibodies and methods of use thereof
EP1532238A4 (en) THERAPEUTIC POLYPEPTIDES, THESE CODING NUCLEIC ACIDS AND METHOD OF USE
EP1539985A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES, AND METHODS OF USE
AU2002365905A8 (en) Transaminases, nucleic acids encoding them and methods of making and using them
EP1399537A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THEM, AND METHODS OF USE
EP1443913A4 (en) THERAPEUTIC POLYPEPTIDES, NUCLEIC ACIDS ENCODING THESE POLYPEPTIDES AND METHODS OF USE THEREOF
EP1549671A4 (en) THERAPEUTIC POLYPEPTIDES, THESE CODING NUCLEIC CAUSE, AND USE PROCESS
AU2002365216A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003304034A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
WO2003060149A9 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use
AU2003270424A8 (en) Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application